Previous Article | Next Article ![]()
J Virol, July 1998, p. 5840-5844, Vol. 72, No. 7
Harvard Medical School, Beth Israel Deaconess
Medical Center, Boston, Massachusetts 02215
Received 3 December 1997/Accepted 25 March 1998
It has been suggested that the inability of the immune response to
control human immunodeficiency virus type 1 (HIV-1) replication may be
due, at least in part, to the capacity of this virus to escape from
immune recognition through mutation. While there is increasing evidence
for the importance of HIV-1-specific CD4+ T cells in
containing HIV-1 spread in the infected individual, little is known
about the consequences of HIV-1 mutation on virus-specific CD4+ T-cell function. The impact of HIV-1 sequence
variation on CD4+ T-helper (Th)- cell function was
assessed with a rhesus monkey model for immune recognition of the HIV-1
envelope (Env) glycoprotein. A series of HIV-1 Env(484-496) variant
peptides were shown to retain the ability to bind to the appropriate
rhesus monkey major histocompatibility complex class II DR molecule.
Peptides bearing substitutions at position 490, however, failed to
drive the proliferation or cytokine secretion of two well-characterized
HXBc2 Env-specific rhesus monkey CD4+ Th-cell lines.
Exogenous costimulation was ineffective in complementing the ability of
the nonstimulatory peptides to induce [3H]thymidine
incorporation by these cells. Finally, HIV-1 Env(484-496) variant
peptides with substitutions at position 490 antagonized the HXBc2 Env
peptide-induced proliferative response of the CD4+ Th-cell
lines. Thus, HIV-1 variants appear to have the capacity to neutralize
the function of virus-specific CD4+ T lymphocytes.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Substitutions in a Major Histocompatibility Complex
Class II-Restricted Human Immunodeficiency Virus Type 1 gp120 Epitope
Can Affect CD4+ T-Helper-Cell Function
*
Corresponding author. Present address: Department of
Microbiology and Immunology, Stanford University Medical Center, D305 Fairchild Building, Stanford, CA 94305. Phone: (650) 723-7296. Fax:
(650) 723-6853. E-mail: clekutis{at}leland.stanford.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»